Related Experiment Video
Updated: May 14, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Impact of recipient-donor risk matching on graft survival after lung transplantation
Michael T Olson1, Ashwini Arjuna2, Mark Shacker3
1Department of General Surgery, Brooke Army Medical Center, Fort Sam Houston, TX; Division of Thoracic Surgery, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ.
Background:
The impact of recipient-donor risk matching on long-term lung transplant outcomes in contemporary practice remains uncertain. As utilization of extended-criteria donors (ECDs) increases, clarifying the relative contributions of recipient risk vs donor marginality is critical.
Methods:
We performed a retrospective analysis of the United Network for Organ Sharing registry, including adult lung transplants from January 2018 through June 2025. Recipients were classified as low-risk (LRR) or high-risk (HRR) using International Society for Heart and Lung Transplantation-based criteria, and donors were categorized as standard criteria (SCD) or extended criteria (ECD). Transplants were grouped: LRR-SCD, LRR-ECD, HRR-SCD, or HRR-ECD. Primary outcome was graft survival at 1, 3, and 5 years. Multivariable Cox regression and restricted mean survival time (RMST) analyses were performed.
Results:
Among 20,635 lung transplants, 4,425 (21.4%) were LRR-SCD, 4,684 (22.7%) LRR-ECD, 5,916 (28.7%) HRR-SCD, and 5,610 (27.2%) HRR-ECD. Composite morbidity increased stepwise from LRR-SCD (28.6%) to HRR-ECD (40.4%) (p < 0.001). Five-year graft survival was similar between LRR-SCD (61.2%) and LRR-ECD (59.4%) groups but significantly lower for HRR-SCD (54.5%) and HRR-ECD (53.4%) (p < 0.001). After adjustment, HRR-SCD (aHR 1.27, 95% CI 1.17-1.38) and HRR-ECD (aHR 1.32, 95% CI 1.22-1.44) had higher graft failure risk vs LRR-SCD, whereas LRR-ECD did not. RMST at 5 years was reduced by 0.27 years in HRR-SCD and 0.33 years in HRR-ECD recipients.
Conclusions:
Recipient risk was the dominant determinant of long-term graft survival. LRRs tolerated ECD lungs without survival penalty, whereas HRRs experienced inferior outcomes regardless of donor quality.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

